NOD1 and NOD2 Genetic Variants in Association with Risk of Gastric Cancer and Its Precursors in a Chinese Population

被引:16
|
作者
Li, Zhe-Xuan [1 ]
Wang, Yu-Mei [1 ]
Tang, Fu-Bing [1 ]
Zhang, Lian [1 ]
Zhang, Yang [1 ]
Ma, Jun-Ling [1 ]
Zhou, Tong [1 ]
You, Wei-Cheng [1 ]
Pan, Kai-Feng [1 ]
机构
[1] Peking Univ, Canc Hosp & Inst, Dept Canc Epidemiol, Key Lab Carcinogenesis & Translat Res,Minist Educ, Beijing 100142, Peoples R China
来源
PLOS ONE | 2015年 / 10卷 / 05期
基金
中国国家自然科学基金;
关键词
HELICOBACTER-PYLORI INFECTION; PRECANCEROUS LESIONS; INNATE IMMUNITY; POLYMORPHISMS; SUSCEPTIBILITY; NOD1/CARD4; RECEPTORS; EVOLUTION; APOPTOSIS; DOMAIN;
D O I
10.1371/journal.pone.0124949
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background Genetic variants of nucleotide-binding oligomerization domain-containing protein (NOD) may influence the outcome of Helicobacter pylori (H. pylori) infection and gastric carcinogenesis. To explore genetic variants of NOD1 and NOD2 in association with gastric cancer (GC) and its precursors, a population-based study was conducted in Linqu County, China. Methods TagSNPs of NOD1 and NOD2 were genotyped by Sequenom MASS array in 132 GCs, and 1,198 subjects with precancerous gastric lesions, and were correlated with evolution of gastric lesions in 766 subjects with follow-up data. Results Among seven tagSNPs, NOD1 rs2709800 and NOD2 rs718226 were associated with gastric lesions. NOD1 rs2709800 TG genotype carriers had a decreased risk of intestinal metaplasia (IM, OR: 0.53; 95% CI: 0.31-0.92), while NOD2 rs718226 G allele (AG/GG) showed increased risks of dysplasia (DYS, OR: 2.96; 95% CI: 1.86-4.71) and GC (OR: 2.35; 95% CI: 1.24-4.46). Moreover, an additive interaction between rs718226 and H. pylori was found in DYS or GC with synergy index of 3.08 (95% CI: 1.38-6.87) or 3.99 (95% CI: 1.55-10.22), respectively. The follow-up data indicated that NOD2 rs2111235 C allele (OR: 0.52; 95% CI: 0.32-0.83) and rs7205423 G allele (OR: 0.56; 95% CI: 0.35-0.89) were associated with decreased risk of progression in H. pylori-infected subjects. Conclusions NOD1 rs2709800, NOD2 rs718226, rs2111235, rs7205423 and interaction between rs718226 and H. pylori infection may be related to risk of gastric lesions.
引用
收藏
页数:14
相关论文
共 50 条
  • [41] The role of NOD1 and NOD2 in host defense against chlamydial infection
    Zou, Yan
    Lei, Wenbo
    He, Zhansheng
    Li, Zhongyu
    FEMS MICROBIOLOGY LETTERS, 2016, 363 (17)
  • [42] NOD1和NOD2与炎性肠病
    王雪纯
    薛丽英
    临床与病理杂志, 2017, 37 (05) : 1053 - 1057
  • [43] NOD1 and NOD2: Molecular targets in prevention and treatment of infectious diseases
    Pashenkov, Mikhail V.
    Dagil, Yulia A.
    Pinegin, Boris V.
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2018, 54 : 385 - 400
  • [44] Genetic variation in NOD1/CARD4 and NOD2/CARD15 immune sensors and risk of osteoporosis
    Soyocak, Ahu
    Ozgen, Merih
    Cosan, Didem Turgut
    Kurt, Hulyam
    Doganer, Fulya
    Armagan, Onur
    Degirmenci, Irfan
    Mutlu, Fezan Sahin
    BIOSCIENCE REPORTS, 2020, 40
  • [45] Analgesic effects of chemically synthesized NOD1 and NOD2 agonists in mice
    Sato, Tadasu
    Shikama, Yosuke
    Shimauchi, Hidetoshi
    Endo, Yasuo
    Takada, Haruhiko
    INNATE IMMUNITY, 2011, 17 (01) : 54 - 59
  • [46] A Salmonella Virulence Factor Activates the NOD1/NOD2 Signaling Pathway
    Keestra, A. Marijke
    Winter, Maria G.
    Klein-Douwel, Daisy
    Xavier, Mariana N.
    Winter, Sebastian E.
    Kim, Anita
    Tsolis, Renee M.
    Baeumler, Andreas J.
    MBIO, 2011, 2 (06):
  • [47] NOD1 and NOD2: Essential Monitoring Partners in the Innate Immune System
    Li, Zhenjia
    Shang, Dejing
    CURRENT ISSUES IN MOLECULAR BIOLOGY, 2024, 46 (09) : 9463 - 9479
  • [48] Cross-talk of Nod1 and Nod2 signaling pathways with IFNγ
    Duerr, Claudia
    Fritz, Joerg
    JOURNAL OF IMMUNOLOGY, 2012, 188
  • [49] Expression and in vitro assessment of tumorigenicity for NOD1 and NOD2 receptors in breast cancer cell lines
    Velloso F.J.
    Sogayar M.C.
    Correa R.G.
    BMC Research Notes, 11 (1)
  • [50] NOD2 variants and the risk of malignant melanoma
    Debniak, T
    Kurzawski, G
    Huzarski, T
    Byrski, T
    Gronwald, J
    Debniak, B
    Rozmiarek, A
    Dziuba, I
    Zlowocka, E
    Suchy, J
    Górski, B
    Cybulski, C
    Mierzejewski, M
    Masojc, B
    Medrek, K
    Oszurek, O
    Lubinski, J
    EUROPEAN JOURNAL OF CANCER PREVENTION, 2005, 14 (02) : 143 - 146